{"transactions":[{"id":738608,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38385,"kind":"person","name":"Galson Steven K","position":1,"cik":"0001495328","reported_name":"Galson Steven K","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2026-06-15T20:30:38.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":33540,"derivative":{"exercise_price":8.5,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":33540},"source":{"system":"sec-edgar","filing":"0000882796-26-000053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000053/form4.xml","form_type":"4"}},{"id":738607,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38385,"kind":"person","name":"Galson Steven K","position":1,"cik":"0001495328","reported_name":"Galson Steven K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-15T20:30:38.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":27794,"source":{"system":"sec-edgar","filing":"0000882796-26-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000053/form4.xml","form_type":"4"}},{"id":1110472,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38385,"kind":"person","name":"Galson Steven K","position":1,"cik":"0001495328","reported_name":"Galson Steven K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Automatic Stock Option Grant","published_at":"2025-06-16T20:19:21.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":27181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":27181,"derivative":{"exercise_price":10.4,"exercise_date":"2026-06-12","expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":27181},"source":{"system":"sec-edgar","filing":"0001171843-25-003912","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003912/ownership.xml","form_type":"4"}},{"id":1110471,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38385,"kind":"person","name":"Galson Steven K","position":1,"cik":"0001495328","reported_name":"Galson Steven K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:19:21.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":24991,"source":{"system":"sec-edgar","filing":"0001171843-25-003912","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003912/ownership.xml","form_type":"4"}},{"id":1479824,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38385,"kind":"person","name":"Galson Steven K","position":1,"cik":"0001495328","reported_name":"Galson Steven K","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2024-06-14T20:23:04.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":49933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":49933,"derivative":{"exercise_price":6.3,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":49933},"source":{"system":"sec-edgar","filing":"0001127602-24-018711","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224018711/form4.xml","form_type":"4"}},{"id":1479823,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38385,"kind":"person","name":"Galson Steven K","position":1,"cik":"0001495328","reported_name":"Galson Steven K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-14T20:23:04.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares purchased by the reporting person on May 13, 2024 were inadvertently reported as being purchased directly by the reporting person but were actually purchased by the reporting person's trust.  The reporting person is a trustee of such trust and the reporting person and members of his family are the sole beneficiaries of the trust. The reporting person is an indirect beneficial owner of the shares held by the trust."}],"balance_after":36431,"source":{"system":"sec-edgar","filing":"0001127602-24-018711","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224018711/form4.xml","form_type":"4"}},{"id":1516576,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38385,"kind":"person","name":"Galson Steven K","position":1,"cik":"0001495328","reported_name":"Galson Steven K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-15T11:14:54.000Z","date":"2024-05-13","kind":"purchase","planned":false,"acquired":true,"shares":21940,"price":5.49,"value":120450.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.48 to $5.49. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":51551,"source":{"system":"sec-edgar","filing":"0001127602-24-015369","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224015369/form4.xml","form_type":"4"}},{"id":1855068,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38385,"kind":"person","name":"Galson Steven K","position":1,"cik":"0001495328","reported_name":"Galson Steven K","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2023-06-15T20:40:41.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":39072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":39072,"derivative":{"exercise_price":8.18,"exercise_date":"2024-06-13","expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":39072},"source":{"system":"sec-edgar","filing":"0001127602-23-018788","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760223018788/form4.xml","form_type":"4"}},{"id":1855067,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38385,"kind":"person","name":"Galson Steven K","position":1,"cik":"0001495328","reported_name":"Galson Steven K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-15T20:40:41.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":16745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":29611,"source":{"system":"sec-edgar","filing":"0001127602-23-018788","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760223018788/form4.xml","form_type":"4"}},{"id":2238273,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38385,"kind":"person","name":"Galson Steven K","position":1,"cik":"0001495328","reported_name":"Galson Steven K","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2022-06-09T20:38:10.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":30022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":30022,"derivative":{"exercise_price":10.79,"exercise_date":"2023-06-07","expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":30022},"source":{"system":"sec-edgar","filing":"0001127602-22-017141","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760222017141/form4.xml","form_type":"4"}},{"id":2238272,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38385,"kind":"person","name":"Galson Steven K","position":1,"cik":"0001495328","reported_name":"Galson Steven K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-09T20:38:10.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":12866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":12866,"source":{"system":"sec-edgar","filing":"0001127602-22-017141","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760222017141/form4.xml","form_type":"4"}},{"id":2582605,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38385,"kind":"person","name":"Galson Steven K","position":1,"cik":"0001495328","reported_name":"Galson Steven K","relationship":{"director":true}}],"security":"Non-Qualified Stock Option","published_at":"2021-09-02T20:25:59.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 1/36 per month for a period of 36 months, beginning on October 1, 2021."}],"balance_after":60000,"derivative":{"exercise_price":16.15,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001127602-21-024770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221024770/form4.xml","form_type":"4"}}]}